Follow
Dominik Menges
Title
Cited by
Cited by
Year
Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021
SW Hanson, C Abbafati, JG Aerts, Z Al-Aly, C Ashbaugh, T Ballouz, ...
JAMA, 2022
331*2022
Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study
D Menges, T Ballouz, A Anagnostopoulos, HE Aschmann, A Domenghino, ...
PLOS ONE 16 (7), e0254523, 2021
2662021
Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome
C Cervia, Y Zurbuchen, P Taeschler, T Ballouz, D Menges, S Hasler, ...
Nature Communications 13 (1), 1-12, 2022
1512022
Drivers of acceptance of COVID-19 proximity tracing apps in Switzerland: panel survey analysis
V von Wyl, M Höglinger, C Sieber, M Kaufmann, A Moser, M Serra-Burriel, ...
JMIR Public Health and Surveillance 7 (1), e25701, 2021
117*2021
Early evidence of effectiveness of digital contact tracing for SARS-CoV-2 in Switzerland
M Salathé, CL Althaus, N Anderegg, D Antonioli, T Ballouz, E Bugnion, ...
Swiss Medical Weekly 150 (5153), 2020
1022020
Long COVID Through a Public Health Lens: An Umbrella Review
V Nittas, M Gao, EA West, T Ballouz, D Menges, S Wulf Hanson, ...
Public Health Reviews, 5, 2022
982022
Systematic early versus late mobilization or standard early mobilization in mechanically ventilated adult ICU patients: systematic review and meta-analysis
D Menges, B Seiler, Y Tomonaga, M Schwenkglenks, MA Puhan, ...
Critical Care 25 (1), 1-24, 2021
652021
Habitat-specific shaping of proliferation and neuronal differentiation in adult hippocampal neurogenesis of wild rodents
N Cavegn, RM Van Dijk, D Menges, H Brettschneider, M Phalanndwa, ...
Frontiers in Neuroscience 7, 59, 2013
412013
A Data-Driven Simulation of the Exposure Notification Cascade for Digital Contact Tracing of SARS-CoV-2 in Zurich, Switzerland
D Menges, HE Aschmann, A Moser, CL Althaus, V Von Wyl
JAMA Network Open 4 (4), e218184-e218184, 2021
40*2021
Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study
T Ballouz, D Menges, A Anagnostopoulos, A Domenghino, HE Aschmann, ...
BMJ 381, 2023
32*2023
The hippocampus of the eastern rock sengi: cytoarchitecture, markers of neuronal function, principal cell numbers, and adult neurogenesis
L Slomianka, T Drenth, N Cavegn, D Menges, SE Lazic, M Phalanndwa, ...
Frontiers in Neuroanatomy 7, 34, 2013
272013
Treatments for metastatic hormone-sensitive prostate cancer: systematic review, network meta-analysis, and benefit-harm assessment
D Menges, HG Yebyo, S Sivec-Muniz, SR Haile, MC Barbier, ...
European Urology Oncology 5 (6), 605-616, 2022
252022
The SwissCovid Digital Proximity Tracing App after one year: Were expectations fulfilled?
P Daniore, T Ballouz, D Menges, V von Wyl
Swiss Medical Weekly 151, w30031, 2021
252021
Adherence and association of digital proximity tracing app notifications with earlier time to quarantine: results from the Zurich SARS-CoV-2 Cohort Study
T Ballouz, D Menges, HE Aschmann, A Domenghino, JS Fehr, MA Puhan, ...
International Journal of Public Health 66, 2021
21*2021
Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts
T Ballouz, D Menges, M Kaufmann, R Amati, A Frei, V von Wyl, JS Fehr, ...
PLOS ONE 18 (2), e0281429, 2023
17*2023
Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort
D Menges, KD Zens, T Ballouz, N Caduff, D Llanas-Cornejo, ...
Nature Communications 13 (1), 1-16, 2022
172022
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region
M Emmenegger, E De Cecco, D Lamparter, RPB Jacquat, J Riou, ...
iScience, 105928, 2023
13*2023
Mental health of individuals infected with SARS-CoV-2 during mandated isolation and compliance with recommendations—A population-based cohort study
A Domenghino, HE Aschmann, T Ballouz, D Menges, D Strebel, S Derfler, ...
PLOS ONE 17 (3), e0264655, 2022
92022
Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit–harm balance modeling study
HG Yebyo, HE Aschmann, D Menges, CM Boyd, MA Puhan
Therapeutic Advances in Chronic Disease 10, 2040622319877745, 2019
92019
Personalising add-on treatment with inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a benefit–harm modelling study
HG Yebyo, J Braun, D Menges, G Ter Riet, M Sadatsafavi, MA Puhan
The Lancet Digital Health 3 (10), e644-e653, 2021
82021
The system can't perform the operation now. Try again later.
Articles 1–20